Remove DNA Remove Engineering Remove Marketing
article thumbnail

New tRNA tech aims to rewrite rare disease treatment

Drug Target Review

One company leading the charge in this revolution is Alltrna , whose pioneering work in engineered transfer RNA (tRNA) therapeutics is offering new hope for patients with rare genetic diseases. we are first focused on engineering tRNAs to restore protein production in diseases caused by premature termination codons.

Disease 80
article thumbnail

Women in Stem with Dr Emily Leproust

Drug Target Review

After some time in that role and launching several products, I received a call from Bill Banyai and Bill Peck, or ‘The Bills’ as we call them, who were building a company around technology that creates DNA by ‘writing’ it on a silicon chip. Because I was put into the highest tier, I was automatically mapped to the engineering track.

DNA 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management

LifeSciVC

The ability of modifying RNA enabled us to sidestep many of the potential risks associated with permanent DNA editing. We aimed to achieve this by modifying and modulating proteins by precisely changing a single alphabet on RNA with the use of an oligonucleotide (think short stretches of chemically modified RNA or DNA).

RNA 68
article thumbnail

Vector Space Biosciences: Leading Innovation in Space Medicine with AI

DrugBank

Space biosciences are on the verge of becoming one of the largest total addressable markets to ever exist, opening up vast opportunities for economic growth and scientific discovery.    In the realm of space exploration, one critical yet often overlooked aspect is the impact of space conditions on human health.

DNA 144
article thumbnail

What Biology Can Learn from Physics

Codon

A zoologist, ecologist, and protein engineer all call themselves “biologists,” but rarely attend the same conferences. This last variable could be just about anything; there are proteins that bind to other proteins (like antibodies), cut other proteins (proteases), or bind DNA (transcription factors).

article thumbnail

Farma: Speculative Gastronomy

Codon

Genetic engineering in the medicine cabinet is one thing; allowing it at the dinner table is another. The chefs at Farma know that by embracing food technologies such as recombinant DNA, precision fermentation, and cell culture, food can become more nutritious and better for the planet. At the dining table. More are still unfolding.

article thumbnail

Key considerations before commencing cell line development

Drug Target Review

The first critical decision is whether to access one of the commercially available host cell line, vector and CLD platforms on the market, or to develop a novel, proprietary system in house. A potential future for host cell lines There have been many recent advances in cell line engineering technologies and our understanding of CHO cells.